See also this year's filing and all EDGAR filings for this company.
PDF Report 0001626971_2022_Corvus_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001626971, Corvus Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 71,312,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 451,000 |
| 3 | remainder_Assets | 37,692,000 |
| 4 | LiabilitiesCurrent | 9,692,000 |
| 5 | LiabilitiesNoncurrent | 2,601,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,564,608 |
| 9 | ResearchAndDevelopmentExpense | 27,874,226 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 37,660,794 |
| 13 | remainder_ComprehensiveNetIncome | -20,425 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 109,455,000 |
| 1 | Liabilities | 12,293,000 |
| 2 | Expenses | 36,438,834 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 97,162,000 |
| 5 | NetIncome | 1,221,960 |
| 6 | ComprehensiveNetIncome | 1,211,748 |
| 7 | BaseVar | 97,934,026 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.50 |
| 9 | EconomicCapitalRatio | 4.03 |
Edgar->Model Mapping
Feature Distribution
Change over Time
